Clinical Trial Results:
A randomized withdrawal, active- and placebo-controlled, double-blind, multi-center Phase III trial assessing safety and efficacy of oral CG5503 PR in subjects with moderate to severe chronic malignant tumor-related pain
Summary
|
|
EudraCT number |
2006-004997-28 |
Trial protocol |
CZ HU AT ES DE IT SK NL BG SE FR |
Global completion date |
04 Jun 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 Feb 2016
|
First version publication date |
10 May 2015
|
Other versions |
|
Summary report(s) |
ClinicalTrials.gov record |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.